OSR Health, Inc. (OSRH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US68840D1028
OSR Health, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.91 m USD |
| Gross profit | 592,905.00 USD |
| Operating income | -18.34 m USD |
| EBIT | -28.45 m USD |
| Net income | -18.01 m USD |
| Diluted EPS – continuing operations | -0.80 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About OSR Health, Inc.
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington.
More stocks
- AQUA POWER SYSTEMS INC. (APSI)
- Glidelogic Corp. (GDLG)
- Blue Star Foods Corp. (BSFC)
- BIO KEY INTERNATIONAL INC (BKYI)
- America Great Health (AAGH)
- enVVeno Medical Corp (NVNO)
- PORTSMOUTH SQUARE INC (PRSI)
- Charging Robotics Inc. (CHEV)
- RenX Enterprises Corp. (RENX)
- CaliberCos Inc. (CWD)
- TaoWeave, Inc. (TWAV)
- Knightscope, Inc. (KSCP)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.